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Purpose: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare, life-
threatening multi-system adverse drug reaction characterized by febrile skin rash, hematologic abnormal-
ities, and involvement of internal organs. We report a case of DRESS syndrome in a child presenting with
primary ophthalmic manifestations.
Case Report: An 11-year-old boy presented with severe pain and diminished vision in both eyes six weeks
after starting carbamazepine therapy for seizure disorder. Ocular examination revealed features of bilateral
acute anterior uveitis, acute onset myopia, and angle closure glaucoma secondary to uveal effusion.
Additionally, the patient was febrile with a generalized maculopapular rash, and blood investigations
revealed eosinophilic leukocytosis. A diagnosis of carbamazepine-induced DRESS syndrome was made,
and carbamazepine therapy was discontinued. Treatment with cycloplegics, topical, and systemic steroids
resulted in prompt clinical recovery.
Conclusion: Ophthalmologists should be aware that hypersensitivity to anticonvulsants, such as carba-
mazepine, can present with bilateral uveitis and uveal effusion along with systemic symptoms. Prompt
diagnosis and treatment can prevent vision loss and life-threatening complications. Patients should be
counselled about potential adverse effects of anticonvulsants before therapy.
Keywords: Anterior Uveitis; Carbamazepine; DRESS Syndrome
J Ophthalmic Vis Res 2019; 14 (3): 382–386
Correspondence to:
Divya Karuppannasamy, MS, DNB. PSG. Institute of
Medical Sciences and Research, Coimbatore 641004,
Tamil Nadu, India.
E-mail: kovaieyecare@yahoo.co.in
Received: 21-02-2018 Accepted: 15-05-2018





This is an open access journal, and articles are distributed under the terms of
the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which
allows others to remix, tweak, and build upon the work non-commercially, as
long as appropriate credit is given and the new creations are licensed under the
identical terms.
How to cite this article: Karuppannasamy D, Andavar A, Arumugam
J, Muthuvel K. DRESS syndrome secondary to carbamazepine therapy
presenting with bilateral acute anterior uveitis and angle closure glaucoma.
J Ophthalmic Vis Res 2019;14:382–386
382 @ 2019 J  O  V R | P  PUBLISHED BY KNOWLEDGE E
DRESS Syndrome Presenting as Uveitis; Karuppannasamy et al
INTRODUCTION
Drug reaction with eosinophilia and systemic
symptoms (DRESS) syndrome is a rare, poten-
tially fatal idiosyncratic reaction characterized by
cutaneous manifestations, hematological changes,
and involvement of internal organs.[1] The inci-
dence of this syndrome ranges from 1 in 1000
to 1 in 10,000 drug exposures. The liver is the
most commonly affected visceral organ.[2] Primary
ocular involvement is uncommon, and only a few
cases have been reported in adults.[3–7] Here, we
report the occurrence of bilateral acute anterior
uveitis and angle closure glaucoma associated
with carbamazepine-induced DRESS syndrome in
a child.
CASE REPORT
An 11-year-old boy was admitted at the ophthal-
mology department with complaints of severe pain
and diminished vision in both eyes for two days.
He had never worn glasses, and his ocular history
was unremarkable. Six weeks earlier, he had been
diagnosedwith a seizure disorder by a pediatrician;
oral carbamazepine therapy (200 mg twice daily)
was started. Three weeks before the onset of
ocular symptoms, he had developed fever and
generalized skin rash, which was diagnosed as
a viral exanthem and managed with supportive
therapy.
Ophthalmic examination revealed a best cor-
rected visual acuity of 20/120 in the right eye and
20/60 in the left eye with −9.0 diopters spherical
(DSph) and −1.0 diopters cylinder (DCyl) at 90o
in the right eye and −10.0 DSph and −1.0 DCyl
at 90o in the left eye. The eyelids were swollen,
and chemosis was noted in both eyes. Anterior
segment examination revealed corneal epithelial
edema, shallow anterior chamber with 3 plus cells,
sluggishly reacting pupil, and clear crystalline lens
in both eyes. Intraocular pressure by Goldmann
applanation tonometry was 45 and 40 mmHg in
the right and left eyes, respectively. Gonioscopy
revealed bilateral 360o appositional angle closure,
and no angle structures were visible. Fundus exam-
ination revealed normal optic disc and vessels with
a cup-to-disc ratio of 0.3. The axial length of the
right eye was 21.91 mm and that of the left eye was
22.05 mm. Considering the acute onset of myopia,
Figure 1. Clinical photograph showing swollen eyelids and
crusted lesions on lips.
bilateral shallow anterior chambers, and angle-
closure glaucoma, ciliochoroidal effusion, probably
due to carbamazepine, was diagnosed.
In addition to the ocular findings, the child was
febrile with a temperature of 39.8oC and had a gen-
eralizedmaculopapular rash. The lips were swollen
with crusted lesions [Figure 1]. Systemic exami-
nation revealed no abnormalities. Investigations
revealed leukocytosis (18.9×103/𝜇L) with increased
neutrophils (14.0 × 103/𝜇L) and eosinophils (1.8 ×
103/𝜇L). Peripheral smear showed a few atypical
lymphocytes and no blast cells. Hemoglobin level
was 12.9 g/dL, and platelet count was 358× 103/𝜇L.
Blood culture tests were negative, and liver func-
tion tests werewithin normal limits. A dermatologist
was consulted for the skin lesions, and DRESS
syndrome was diagnosed.
Carbamazepine was discontinued and substi-
tuted with levetiracetam. Treatment was initiated
with homatropine, timolol, and topical steroids,
along with intravenous mannitol (1 g/kg body
weight). His symptoms improved dramatically after
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Figure 2. Anterior segment photograph of the right eye
showing posterior synechiae.
two doses of intravenous dexamethasone (4 mg).
Ocular examination on the third day revealed a
clear cornea, deep anterior chamber with over
three cells in both eyes, and posterior synechiae in
the right eye [Figure 2]. Intraocular pressure in the
right and left eyes was 6 and 5mmHg, respectively.
Fundus examination revealed choroidal folds in the
macula and serous elevation of the retina along
with scattered retinal hemorrhages [Figure 3].
Along with topical steroids and homatropine,
oral prednisolone therapy was started (initial dose,
1 mg/kg body weight) and subsequently tapered.
At the three-week follow-up, uveitis and retinal
hemorrhages had resolved [Figure 4]. Unaided
visual acuity was 20/20, and intraocular pressure
was 16 mm Hg in both eyes.
DISCUSSION
Carbamazepine is not included among drugs caus-
ing uveitis or angle closure glaucoma. A literature
search revealed one case of elevated intraocu-
lar pressure associated with carbamazepine in a
patient with pseudoexfoliation glaucoma.[8]
Aromatic anticonvulsants, such as carba-
mazepine, phenytoin, and phenobarbitone, are
the most common causes of DRESS; it usually
occurs three weeks to three months after starting
the drug therapy.[9] Although many children
receive anticonvulsant therapy, DRESS is rare in
childhood, with fewer cases reported in children
compared to adults.[10] The exact pathogenesis
of this syndrome is poorly understood. The
implicated mechanisms include abnormalities in
drug metabolism with accumulation of reactive
Figure 3. Fundus photograph of both eyes showing choroidal
folds at the macula, retinal hemorrhages, and serous retinal
detachment.
Figure 4. Fundus photograph at the three-week follow-up
showing normal optic disc and macula.
metabolites, genetic predisposition of individuals
to certain human leukocyte antigen (HLA)
haplotypes, and interactions between herpes
viruses and antiviral and drug-specific immune
responses.[11]
Currently, there is no consensus on the best
diagnostic criteria for DRESS syndrome. The orig-
inal criteria were proposed by Bocquet et al.[1]
Two separate scoring systems based on the
diagnostic criteria have been developed by the
Japanese Research Committee on Severe Cuta-
neous Adverse Reaction ( J-SCAR) and the Euro-
pean Registry of Severe Cutaneous Adverse Reac-
tion (RegiSCAR).[11, 12] The RegiSCAR, which out-
lines seven inclusion criteria, is the most widely
used [Table 1].
Our patient fulfilled three of the four main criteria
for the diagnosis of DRESS syndrome (as proposed
by the European RegiSCAR), namely, acute rash,
fever > 38oC, and abnormal eosinophil and lym-
phocyte counts. No internal organs were involved.
This can be attributed to the timely discontin-
uation of carbamazepine and prompt initiation
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Table 1. Diagnostic criteria for DRESS syndrome
Bocquet et al[1] J-SCAR RegiSCAR
All the three criteria are required Typical DRESS: all the seven criteria are
required
Atypical DIHS: only the first five are
required
Presence of more than three of the following
criteria
1. Cutaneous drug eruption 1. Maculopapular rash developing three




Eosinophils ≥ 1.5 × 109/L and the
presence of atypical lymphocytes
2. Prolonged clinical symptoms after
discontinuing the causative drug
2. Acute rash
3. Systemic involvement:
lymphadenopathy > 2 cm,
hepatitis with transaminase levels
twice the normal, interstitial
nephritis, pneumonitis, and carditis
3. Fever > 38oC 3. Reaction suspected to be drug-related
4. Hepatic abnormalities (ALT >100 U/L)
or involvement of another organ
4. Fever > 38oC
5. Leukocytosis, eosinophils ≥ 1.5 ×
109/L, and the presence of atypical
lymphocytes (> 5%)
5. Lymphadenopathy involving at least two
sites
6. Lymphadenopathy 6. Involvement of one internal organ (liver,
kidney, or others)
7. Reactivation of HHV-6 7. Hematologic abnormalities: lymphocyte
count above or below normal limits,
eosinophil count above laboratory limits,
platelet count below laboratory limits.
ALT, Alanine transaminase; DIHS, drug-induced hypersensitivity syndrome; HHV, human herpes virus
of steroid therapy. Differential diagnosis in our
patient includes viral infections, such as dengue,
chikungunya, and hematological disorders, such
as leukemia, anemia, and thrombocytopenia, all
of which can present with retinal hemorrhages,
serous retinal detachment, and uveitis.[13–15]
A clear temporal relationship between the
administration of carbamazepine and onset of
symptoms (three weeks), peripheral blood picture,
an absence of findings in the clinical history and
examination of the child suggestive of infection
or neoplasia, and bilateral acute onset myopia
with angle closure prompted us to suspect a
drug-induced adverse reaction. The assessment of
causality using the Naranjo Adverse Drug Reac-
tion Probability Scale established a “probable”
relationship (score of 6) with carbamazepine in the
patient.[16]
Ocular involvement is a rare feature of DRESS
syndrome and to the best of our knowledge, only
five cases have been reported in literature. Uveitis
(anterior, intermediate, and panuveitis) has been
noted in all the cases. Reactivation of herpes
viruses (human herpesvirus 6 and Epstein-Barr
virus) were noted in two patients who had multi-
organ involvement.[3–7]
We assume that the inflammation of the uveal
tract and accumulation of exudate had resulted
in uveal effusion. This led to the anterior dis-
placement of the iris and lens diaphragm, even-
tually resulting in acute onset myopia, shallow
anterior chamber, appositional angle closure, and
elevation of intra ocular pressure in our patient.
Cycloplegics promoted posterior rotation of the iris-
lens diaphragm, and steroid therapy attenuated
the allergic-type drug reaction, thereby stabilizing
the blood-aqueous barrier and ensuring prompt
recovery.
In contrast to other adverse drug reactions,
dynamic changes in immune response have been
reported in DRESS syndrome.[17] Hence, the uveal
tract with its rich network of macrophages and
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major histocompatibility complex (MHC) class II
dendritic cells is most likely to be affected in
patients with ocular involvement.
Ophthalmologists should be aware that hyper-
sensitivity to anticonvulsants, such as carba-
mazepine, can present with bilateral uveitis and
uveal effusion along with systemic symptoms.
Given the delayed onset after the initiation of
treatment with the offending drug, systemic symp-
toms, and potentially fatal multi-organ involvement,
a high index of suspicion is necessary to pre-
vent complications. Additionally, it is necessary to
inform the patient about the adverse effects of
carbamazepine before prescribing it.
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